Unichem Laboratories has received Establishment Inspection Report (EIR) for the Post Marketing Adverse Drug Experience inspection conducted at Unichem Bhavan, Prabhat Esate in Mumbai by the US Food and Drug Administration (USFDA) from June 25, 2018 to June 29, 2018, indicating closure of inspection.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
